Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
sharewise is moving On the weekend of 22/23 August the new sharewise becomes the main site. Have a look now and tell us what you miss. Go to the new sharewise What changes
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

Karyopharm Therapeutics Inc. buy Royal Bank of Canada

Karyopharm Therapeutics Inc.
Start price
€1.67
03.08.23 / 50%
Target price
€3.65
03.08.24
Performance (%)
-54.66%
End price
€0.76
04.08.24
Summary
This prediction ended on 04.08.24 with a price of €0.76. Massive losses of -54.66% were the result for the BUY prediction by Royal_Bank_of_Canada. Royal_Bank_of_Canada has a follow-up prediction for Karyopharm Therapeutics Inc. where he still thinks Karyopharm Therapeutics Inc. is a Buy. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Karyopharm Therapeutics Inc. - - - -
iShares Core DAX® -1.586% 5.028% 6.332% 64.061%
iShares Nasdaq 100 -4.148% -0.125% 25.735% 86.918%
iShares Nikkei 225® -6.302% 0.528% 41.384% 77.872%
iShares S&P 500 -3.225% 0.470% 20.449% 68.192%

Comments by Royal_Bank_of_Canada for this prediction

In the thread Karyopharm Therapeutics Inc. diskutieren
Prediction Buy
Perf. (%) -54.66%
Target price 3.651
Change
Ends at 03.08.24

Karyopharm Therapeutics Inc. (NASDAQ: KPTI) had its price target lowered by analysts at Royal Bank of Canada from $5.00 to $4.00. They now have an "outperform" rating on the stock.
Ratings data for KPTI provided by MarketBeat

Royal Bank of Canada 
0
Report Share
03.08.23
In the thread Trading Karyopharm Therapeutics Inc.
Prediction Buy
Perf. (%) -54.66%
Target price 3.651
Change
Ends at 03.08.24

Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten

Royal Bank of Canada 
0
Report Share
04.08.24

Current prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.

buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
04.11.25
€16.51
04.11.26
-
25.02.25

Royal Bank of Canada 
04.11.25 50%

Stopped prediction by Royal_Bank_of_Canada for Karyopharm Therapeutics Inc.

buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
21.07.26
-
21.07.27
-
25.02.25

Royal Bank of Canada 
21.07.26 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.54
13.05.25
€29.71
13.05.26
-
14.05.26

Royal Bank of Canada 
13.05.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.59
20.02.25
€2.86
20.02.26
-6.32%
21.02.26

Royal Bank of Canada 
20.02.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.61
10.02.25
€2.91
10.02.26
-9.57%
11.02.26

Royal Bank of Canada 
10.02.25 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.72
07.08.24
€2.75
07.08.25
-25.10%
08.08.25

Royal Bank of Canada 
07.08.24 50%
buy
Karyopharm Therapeutics Inc.

Start price
Target price
Perf. (%)
€0.84
03.11.23
€2.80
03.11.24
-1.41%
04.11.24

Royal Bank of Canada 
03.11.23 50%